DJ Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ rallied 3.07% to $90.53 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.44% to 7,365.46 and Dow Jones Industrial Average falling 0.09% to 51,666.84.
The stock's rise snapped a three-day losing streak.
Abbott Laboratories closed 34.90% below its 52-week high of $139.06, which the company reached on June 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 3.37% to $239.08, Pfizer Inc. $(PFE)$ fell 1.44% to $24.72, and Merck & Co. Inc. $(MRK)$ rose 3.57% to $119.60.
Trading volume (12.0 M) remained 1.7 million below its 50-day average volume of 13.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 23, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.